On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.
All content for The MedTalk Podcast is the property of The MedTalk Podcast and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.
The FemTech Series: Analysing the risk of breast cancer recurrence
The MedTalk Podcast
18 minutes 43 seconds
1 year ago
The FemTech Series: Analysing the risk of breast cancer recurrence
In this episode of The FemTech Series, you can hear Olivia Friett, editor of Medical Plastics News talk to Hemmel Amrania PhD, CEO of Digistain, a company that has won multiple awards for its transformative breast cancer biomarker analytics.
The MedTalk Podcast
On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.
